170 related articles for article (PubMed ID: 12753284)
21. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation.
Monier-Faugere MC; Mawad H; Qi Q; Friedler RM; Malluche HH
J Am Soc Nephrol; 2000 Jun; 11(6):1093-1099. PubMed ID: 10820173
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
[TBL] [Abstract][Full Text] [Related]
23. Posttransplant bone disease: evidence for a high bone resorption state.
Cayco AV; Wysolmerski J; Simpson C; Mitnick MA; Gundberg C; Kliger A; Lorber M; Silver D; Basadonna G; Friedman A; Insogna K; Cruz D; Bia M
Transplantation; 2000 Dec; 70(12):1722-8. PubMed ID: 11152104
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
[TBL] [Abstract][Full Text] [Related]
25. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
26. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
[TBL] [Abstract][Full Text] [Related]
28. Biochemical parameters associated with low bone density in healthy men and women.
Sherman SS; Tobin JD; Hollis BW; Gundberg CM; Roy TA; Plato CC
J Bone Miner Res; 1992 Oct; 7(10):1123-30. PubMed ID: 1456082
[TBL] [Abstract][Full Text] [Related]
29. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.
Dumoulin G; Hory B; Nguyen NU; Bresson C; Fournier V; Bouhaddi M; Chalopin JM; Saint-Hillier Y; Regnard J
Am J Kidney Dis; 1997 May; 29(5):746-53. PubMed ID: 9159310
[TBL] [Abstract][Full Text] [Related]
30. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function.
Akaberi S; Lindergård B; Simonsen O; Nyberg G
Transplantation; 2006 Sep; 82(6):749-52. PubMed ID: 17006320
[TBL] [Abstract][Full Text] [Related]
31. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Ordi J; Rimola A; Rodés J; Muñoz-Gómez J
Osteoporos Int; 2001; 12(6):484-92. PubMed ID: 11446565
[TBL] [Abstract][Full Text] [Related]
32. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
[TBL] [Abstract][Full Text] [Related]
33. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients.
Malyszko J; Malyszko JS; Pawlak K; Konstantynowicz J; Wolczynski S; Kaczmarski M; Mysliwiec M
Transplant Proc; 2005 Jun; 37(5):2151-3. PubMed ID: 15964364
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
Savaj S; Ghods FJ
Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
[TBL] [Abstract][Full Text] [Related]
35. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
Giannini S; D'Angelo A; Nobile M; Carraro G; Rigotti P; Silva-Netto F; Pavan S; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
J Bone Miner Res; 2002 Oct; 17(10):1768-73. PubMed ID: 12369780
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive agents and bone disease in renal transplant patients with hypercalcemia.
Sessa A; Esposito A; Iavicoli GD; Lettieri E; Dente G; Costa C; Bergallo M; Rossano R; Capuano M
Transplant Proc; 2010 May; 42(4):1148-55. PubMed ID: 20534247
[TBL] [Abstract][Full Text] [Related]
37. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation.
Briner VA; Thiel G; Monier-Faugere MC; Bognar B; Landmann J; Kamber V; Malluche HH
Transplantation; 1995 May; 59(10):1393-400. PubMed ID: 7770924
[TBL] [Abstract][Full Text] [Related]
38. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation.
de Sévaux RG; Hoitsma AJ; van Hoof HJ; Corstens FJ; Wetzels JF
Nephron Clin Pract; 2003 Jan; 93(1):C21-8. PubMed ID: 12411755
[TBL] [Abstract][Full Text] [Related]
39. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
[TBL] [Abstract][Full Text] [Related]
40. [Bone metabolism as assessed with selected markers of bone turnover as well as densitometry analysis in patients after successful kidney transplantation].
Giza D; Stompór T; Katra B; Sieradzki J; Sułowicz W
Przegl Lek; 2001; 58(11):979-84. PubMed ID: 11987839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
